期刊文献+

芪灯明目胶囊对高血糖大鼠血视网膜屏障影响的研究 被引量:8

Effect of Chinese medicine Qidengmingmu capsule on the STZ induced hyperglycemia rats blood-retinal barrier
暂未订购
导出
摘要 目的:观察链脲佐菌素(STZ)诱发糖尿病大鼠在造模后血-视网膜屏障(blood-retina barrier,BRB)变化情况,并以阳性药为对照研究中药芪灯明目胶囊对STZ诱发糖尿病大鼠的视网膜血管渗漏影响。方法:采用STZ腹腔注射制作糖尿病大鼠模型,在造模后6mo内各时点(2wk;1,2,3,4,5,6mo)采用伊文思蓝灌注示踪显示血-视网膜的渗漏情况,在造模后3mo开始用中药芪灯明目胶囊(低中高剂量组分别给予125,250,500mg/kg体质量剂量的胶囊内容物灌胃),对照组用安多明胶囊(200mg/kg体质量剂量,相当于10倍成人剂量),灌胃3mo,观察药物对BRB的影响。结果:STZ糖尿病大鼠在2wk即可出现BRB的损害,并随着高血糖状态的持续而不断加重。对造模3moSTZ糖尿病模型大鼠连续灌胃中药芪灯治疗3mo,结果提示:中药芪灯对STZ糖尿病BRB有保护作用,可明显减少视网膜血管的渗漏。结论:STZ糖尿病模型大鼠在早期即可出现BRB损害,并随着高血糖的持续而加重,中药芪灯明目胶囊可减少高血糖导致的BRB损害。 AIM : To observe retinal vessel leakage of streptozotocin (STZ) induced diabetic rat, and the effect of traditional Chinese medicine on it. METHODS: We induced diabetic rat model by peritoneal injection of STZ, after the blood glucose raised, we used Evans blue to trace the leakage of blood-retina barrier (BRB) every month. After blood glucose rose three months later, we treated the Chinese medicine group diabetic rat with Qidengmingmu capsule. There were three groups of different dose, low dose group of 125mg/kg, middle dose group of 250mg/kg, high dose group of 500mg/kg. The control group was treated with calcium dobesilate (200mg/kg). After three months treated by medicine, the leakage of rat blood- retina barrier was evaluated. RESULTS: The damage of BRB and visual function occurred at two week after the blood glucose rose, and the damage aggravated with the continuing of high diabetic. But after the Chinese medicine treated three months, the rat's retina vessel leakage was reduced. CONCLUSION: BRB break down and visual acuity damage appears in early phase of STZ diabetic rat and get worse as the hyperglycemia keep on. The Chinesemedicine Qidengmingmu capsule can prevent the vessel leakage by damage of BRB.
出处 《国际眼科杂志》 CAS 2013年第6期1077-1080,共4页 International Eye Science
基金 国家科技重大专项-重大新药创制(No.2009ZX09102-147) 国家自然科学基金(No.81001483)~~
关键词 芪灯明目胶囊 糖尿病 血-视网膜屏障 伊文思蓝 Qidengmingmu capsule diabetes blood-retina barrier Evans blue
  • 相关文献

参考文献19

二级参考文献86

  • 1李才锐,姜德咏.糖尿病视网膜病变动物模型[J].国外医学(眼科学分册),2005,29(1):44-48. 被引量:13
  • 2李强,段俊国,张富文,刘冀,吴春晓.自发性糖尿病大鼠视网膜病变模型的评价[J].眼科研究,2007,25(2):85-85. 被引量:6
  • 3王竞 张水湛 等.导升明治疗单纯型糖尿病视网膜病变的临床研究[J].中华眼底病杂志,1995,11(4):224-224.
  • 4李艳,李筱荣,刘巨平,袁佳琴.糖尿病大鼠血视网膜屏障损伤观察[J].中华眼底病杂志,2007,23(4):289-290. 被引量:5
  • 5Oliver JA. Adenylate cyclase and protein kinase C mediate opposite actions on endothelial junctions [ J ]. J Cell Physiol, 1990, 145 (3) :536-542.
  • 6Takeo-Goto S, Doi M, Ma N, Goto R, Semba R, Uji Y. Immunohistochemical localization of amino acids in the diabetic retina of Goto-Kakizaki rats[ J]. Ophthalmic Res, 2002,34 ( 3 ) : 139- 145.
  • 7Ido Y, McHowat J, Chang KC, Arrigoni-Martelli E, Orfalian Z, Kilo C. Neural dysfunction and metabolic imbalances in diabetic rats. Prevention by acetyl-L-camitine [ J ]. Diabetes, 1994, 43 (12) : 1469-1477.
  • 8Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses [ J ]. FASEB J, 1995,9 (7) :484-496.
  • 9Shiba T, Inoguehi T, Sportsman JR, Heath WF, Bursell S, King GL. Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation[ J]. Am J Physiol, 1993, 265 (5 Pt 1 ) : E783-E793.
  • 10Xia P, Inoguchi T, Kern TS, Engerman RL, Oates P J, King GL. Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia[ J ]. Diabetes, 1994,43 ( 9 ) : 1122-1129.

共引文献335

同被引文献145

引证文献8

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部